Commercial influence and covid-19

Editorial warns that whatever the evidence ultimately shows about remdesivir’s benefits and harms, commercial influence once again seems to be driving overly positive perceptions of a still unproved drug. Rigorous and independent evaluation of tests and treatments is needed.

British Medical Journal